| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 02/06/2001 | US6184393 Pyronin antibacterials, process and novel intermediates thereto |
| 02/06/2001 | US6184221 Antiarrhythmia agents, antiulcer agents |
| 02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 01/31/2001 | EP1071640A1 Asymmetric synthesis of 2-aryl-1-substituted butan-2,3-diols |
| 01/31/2001 | CN1282326A Anilide derivative, production and use thereof |
| 01/31/2001 | CN1282319A Aminobutanoic acid derivatives |
| 01/31/2001 | CN1282243A Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative |
| 01/31/2001 | CN1061343C Process for preparation of N-acetyl neuraminic acid derivatives |
| 01/30/2001 | USRE37035 Phenylacetic acid benzylamides |
| 01/25/2001 | WO2001005758A2 Indoles and indazoles for the treatment of migraine |
| 01/25/2001 | WO2001005392A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | CA2378047A1 Heterocyclic compounds for the treatment of migraine |
| 01/25/2001 | CA2374052A1 Method for treating chronic pain using mek inhibitors |
| 01/24/2001 | EP1070709A1 Novel pyrylium compound, process for making the same, nucleic acid stain, and labeled nucleic acid |
| 01/24/2001 | EP1070058A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/23/2001 | US6177457 Cyclization of chemical intermediates; fungicides |
| 01/23/2001 | US6177409 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1H)ons derivatives from aminomonosaccharides or aminoitols, products obtained by this method and their applications |
| 01/17/2001 | EP1068180A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/16/2001 | US6174867 Inhibition of the binding of a toxin or organism to its corresponding cell surface receptor; e.g., heat-labile enterotoxin or cholera toxin or enterovirulent organisms; bactericides, viricides, fungicides |
| 01/10/2001 | EP1066258A1 Aryl phenyl substituted cyclic ketoenols |
| 01/10/2001 | CN1279674A 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analoguse), their preparation and their use in the treatment of neurological disorders |
| 01/10/2001 | CN1279673A ((Cyclo) alkyl substituted-.gamma.-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 01/10/2001 | CN1279669A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 01/10/2001 | CN1279667A 4(3)-substituted-4(3)-aminonethyl-(thioxo)pyran(thiapyran)or-piperidine derivatives(=gabapendin analogues), their preparation and their use in treatment of neurological disorders |
| 01/09/2001 | US6172061 Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative |
| 01/09/2001 | US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents |
| 01/04/2001 | WO2001000606A1 Process for selective lactonization |
| 01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 01/04/2001 | CA2342361A1 Process for selective lactonization |
| 01/03/2001 | EP1064285A1 Novel cephalotaxane derivatives and process for their preparation |
| 01/03/2001 | EP1064275A1 Process for producing simvastatin and/or its derivatives |
| 01/03/2001 | EP0787127B1 5-lipoxygenase inhibitors |
| 01/03/2001 | CN1060172C Substituted biphenyl sulfonamide endothelin antagonists |
| 01/02/2001 | US6169181 Compounds useful to treat retroviral infections |
| 12/26/2000 | US6166226 Synthesis of aryl ethers |
| 12/26/2000 | US6166006 Having antagonistic activity on mcp-1 (monocyte chemoattractant protein-1) receptor; antiinflammatory agents |
| 12/26/2000 | US6165757 Nitrogen feed in statin fermentation |
| 12/21/2000 | WO2000076953A1 Benzene derivatives, preparation method and pharmaceutical compositions containing same |
| 12/21/2000 | WO2000053581A3 Heterocyclic compounds having antitumor activity |
| 12/21/2000 | WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 12/20/2000 | EP1061066A2 Fluoromethoxyacrylic acid derivatives, intermediates in the preparation of pest control agents |
| 12/20/2000 | CN1277608A Recovery of gamma-pyrones |
| 12/13/2000 | EP1058550A1 Substituted semicarbazides and the use thereof |
| 12/07/2000 | WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 12/07/2000 | WO2000073289A1 Alpha-phenyl-beta-ketosulfone |
| 12/06/2000 | EP1056737A1 Process for the preparation of simvastatin and derivatives thereof |
| 12/06/2000 | EP1056733A1 Histamine h3 receptor ligands |
| 12/06/2000 | EP1056717A1 Arylphenyl-substituted cyclic keto-enols |
| 12/05/2000 | US6156506 Method for detecting a target substance in a sample, utilizing pyrylium compound |
| 11/30/2000 | WO2000071546A1 Method for separating analogous organic compounds |
| 11/30/2000 | WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 11/30/2000 | DE19924668A1 Substituierte alpha-Phenyl-beta-Ketosulfone Substituted alpha-phenyl-beta-ketosulfones |
| 11/30/2000 | CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds |
| 11/29/2000 | EP1055671A1 Process for producing simvastatin |
| 11/29/2000 | EP1054993A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 11/29/2000 | EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 11/23/2000 | WO2000069855A2 Furanone derivatives as inhibitors of cathepsin s |
| 11/23/2000 | WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 11/23/2000 | WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 11/23/2000 | CA2374297A1 Furanone derivatives as inhibitors of cathepsin s |
| 11/23/2000 | CA2373500A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors |
| 11/23/2000 | CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 11/22/2000 | EP1053233A1 Hydroxamic and carboxylic acid derivatives |
| 11/22/2000 | EP1052982A1 AMINOTETRALINS AS 5-HT 1D$g(a)? AGONISTS |
| 11/16/2000 | WO2000068203A1 Cyclic compounds and uses thereof |
| 11/16/2000 | WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 11/16/2000 | WO2000015634A3 Hiv protease inhibitors |
| 11/16/2000 | CA2373073A1 Cyclic compounds and uses thereof |
| 11/15/2000 | EP1052291A2 Fluorescent stain containing pyrylium salt or its similar salt, detection method of nucleic acid by use of it |
| 11/15/2000 | EP1051387A1 Anticancer platinum (iv) complexes for oral administration |
| 11/14/2000 | US6147188 Irreversible cathepsin or calpain inhibitors |
| 11/14/2000 | US6147036 Mixture of unsaturated compound and carboxylic compound |
| 11/14/2000 | US6146718 Use in vertical orientation system or various display systems, such as in-plain switching, the thin film transistor, twisted nematic, or super twisted nematic systems |
| 11/09/2000 | WO2000066601A1 Method for preparing aloin by extraction |
| 11/09/2000 | WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 11/09/2000 | WO2000028981A3 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor |
| 11/08/2000 | EP1049537A2 Catalytic compositions and methods for asymmetric allylic alkylation |
| 11/08/2000 | CN1058294C Method for preparation of compound named 'Leustroducsins' |
| 11/07/2000 | US6143769 Phenylacetic acid benzylamides |
| 11/02/2000 | WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 11/02/2000 | EP1048640A1 Apoptosis inhibitors |
| 11/02/2000 | EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 11/01/2000 | CN1272105A Compound containing six-membered rings, processes for their preparation, and their use as medicaments |
| 11/01/2000 | CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 10/31/2000 | US6140368 Viricidal properties against retroviruses; inhibitors of hiv reverse transcriptase and/or hiv integrase; aids therapy; nontoxic; also topical treatment of retroviral diseases, e.g. herpes simplex. |
| 10/31/2000 | US6140358 Substituted phenyl keto enols as pesticides and herbicides |
| 10/26/2000 | WO2000063198A1 2,2-disubstituted cyclic ether derivatives and hair tonics containing the same |
| 10/26/2000 | WO2000063165A1 Mmp inhibitor |
| 10/25/2000 | EP1045839A2 Novel amines as pharmaceutical agents |
| 10/25/2000 | EP1045834A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 10/24/2000 | US6136986 Reacting substituted acrolein compound with acrylates, acroleins, acrolein acetals, allyl alcohols or allyl ethers to give 3,4-dihydro-2h-pyrans, reacting with acid, followed by reacting with substitueted vinyl ketone, dehydrogenation |
| 10/19/2000 | WO2000061556A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 10/19/2000 | WO2000061541A2 Pharmaceutical compounds |
| 10/19/2000 | WO2000061537A2 Pharmaceutical compounds |
| 10/19/2000 | CA2370425A1 Pharmaceutical compounds |
| 10/19/2000 | CA2369103A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 10/18/2000 | EP1043990A1 Pyronin antibacterials, process and novel intermediates thereto |
| 10/17/2000 | US6133485 Asymmetric synthesis of 2-(2,4-difluorophenyl)-1-heterocycl-1-yl butan-2,3-diols |